Cargando…

Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States

BACKGROUND: The study evaluated the cost of baroreflex activation therapy plus guideline directed therapy (BAT + GDT) compared to GDT alone for HF patients with reduced ejection fraction and New York Heart Association Class III or II (with a recent history of III). Baroreflex activation therapy (BAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bisognano, John, Schneider, John E., Davies, Shawn, Ohsfeldt, Robert L., Galle, Elizabeth, Stojanovic, Ivana, Deering, Thomas F., Lindenfeld, JoAnn, Zile, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995802/ https://www.ncbi.nlm.nih.gov/pubmed/33771104 http://dx.doi.org/10.1186/s12872-021-01958-y

Ejemplares similares

An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany
por: Borisenko, Oleg, et al.
Publicado: (2018)

Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure
por: Lindenfeld, JoAnn, et al.
Publicado: (2021)

Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta‐analysis of randomized controlled trials
por: Coats, Andrew J.S., et al.
Publicado: (2022)

Endovascular Baroreflex Amplification With the MobiusHD Device in Patients With Heart Failure and Reduced Ejection Fraction: Interim Analysis of the First-in-Human Results
por: Piayda, Kerstin, et al.
Publicado: (2022)

Heart Failure Medical Therapy: A Review for Structural/Interventional Cardiologists
por: Pipilas, Alexandra, et al.
Publicado: (2022)

Role of Diuretics and Ultrafiltration in Congestive Heart Failure
por: Shchekochikhin, Dmitry, et al.
Publicado: (2013)

Respiratory patterns and baroreflex function in heart failure
por: Radaelli, Alberto, et al.
Publicado: (2023)

A case report of ivabradine used for heart rate control of atrial fibrillation in acute decompensated heart failure
por: Hardison, Edward, et al.
Publicado: (2022)

Considerations for Heart Failure Care During the COVID-19 Pandemic
por: DeFilippis, Ersilia M., et al.
Publicado: (2020)

In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
por: Cox, Zachary L, et al.
Publicado: (2022)

Economic evaluation of cardiac magnetic resonance with fast-SENC in the diagnosis and management of early heart failure
por: Schneider, John E., et al.
Publicado: (2019)

Medication regimen complexity in ambulatory older adults with heart failure
por: Cobretti, Michael R, et al.
Publicado: (2017)

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study
por: Gronda, Edoardo, et al.
Publicado: (2014)

Markers of diuretic resistance in emergency department patients with acute heart failure
por: Doering, Andrew, et al.
Publicado: (2017)

Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME
por: Pellicori, Pierpaolo, et al.
Publicado: (2020)

Acute Effects of Vagotomy on Baroreflex Equilibrium Diagram in Rats with Chronic Heart Failure
por: Kawada, Toru, et al.
Publicado: (2016)

Outcomes of Surgeries Performed in Physician Offices Compared With Ambulatory Surgery Centers and Hospital Outpatient Departments in Florida
por: Ohsfeldt, Robert L, et al.
Publicado: (2017)

Comparison of clinical symptoms and bioimpedance to pulmonary capillary wedge pressure in heart failure
por: Polcz, Monica, et al.
Publicado: (2022)

Calibration of Baroreflex Equilibrium Diagram Based on Exogenous Pressor Agents in Chronic Heart Failure Rats
por: Kawada, Toru, et al.
Publicado: (2015)

The efficacy of baroreflex activation therapy for heart failure: A meta-analysis of randomized controlled trials
por: Cai, Guoqiang, et al.
Publicado: (2020)

Impaired Baroreflex Function in an Ovine Model of Chronic Heart Failure Induced by Multiple Coronary Microembolizations
por: Abukar, Yonis, et al.
Publicado: (2019)

Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review
por: Molina‐Linde, Juan Máximo, et al.
Publicado: (2023)

Rationale and design of the EMPERIAL‐Preserved and EMPERIAL‐Reduced trials of empagliflozin in patients with chronic heart failure
por: Abraham, William T., et al.
Publicado: (2019)

Baroreflex mechanisms and response to exercise in patients with heart disease
por: Fukuma, Nagaharu, et al.
Publicado: (2012)

Clinical and haemodynamic correlates of heart rate turbulence as a non-invasive index of baroreflex sensitivity in chronic heart failure
por: La Rovere, Maria Teresa, et al.
Publicado: (2011)

Contemporary Management of Secondary Mitral Regurgitation
por: Goel, Kashish, et al.
Publicado: (2020)

Editorial: Baroreflex activation is a novel therapy for heart failure independent of left ventricular systolic function
por: Kishi, Takuya
Publicado: (2014)

Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2017)

Updates on Baroreflex Activation Therapy and Vagus Nerve Stimulation for Treatment of Heart Failure With Reduced Ejection Fraction
por: Babar, Natasha, et al.
Publicado: (2022)

Ventricular-Vascular Uncoupling in Heart Failure: Effects of Arterial Baroreflex-Induced Sympathoexcitation at Rest and During Exercise
por: Mannozzi, Joseph, et al.
Publicado: (2022)

Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy
por: Nottebohm, Pia I., et al.
Publicado: (2022)

Baroreflex activation therapy in advanced heart failure therapy: insights from a real‐world scenario
por: Guckel, Denise, et al.
Publicado: (2022)

Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience
por: Blanco, Carola, et al.
Publicado: (2023)

Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review
por: Schmidt, Rodrigo, et al.
Publicado: (2020)

Oscillatory Pattern of Sympathetic Nerve Bursts Is Associated With Baroreflex Function in Heart Failure Patients With Reduced Ejection Fraction
por: Toschi-Dias, Edgar, et al.
Publicado: (2021)

Baroreflex sensitivity but not microvolt T-wave alternans can predict major adverse cardiac events in ischemic heart failure
por: Kaufmann, Damian K., et al.
Publicado: (2022)

Extracorporeal Membrane Oxygenation as a Treatment for Branch Pulmonary Artery Rupture Following Right Heart Catheterisation
por: Agrawal, Vineet, et al.
Publicado: (2022)

Early urine electrolyte patterns in patients with acute heart failure
por: Collins, Sean P., et al.
Publicado: (2018)

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
por: Kansal, Anuraag R., et al.
Publicado: (2016)

Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial
por: Shahim, Bahira, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oc25iq1gp86skjip1sppfnrcuo